News
Novavax finally won approval of a Covid-19 vaccine after facing setback after setback that caused the stock to plunge more ...
Novavax Inc. jumped after US regulators fully approved its Covid vaccine, easing investors’ concerns after the clearance was ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
The vaccine will only be available to those at high risk from COVID—excluding those who may need it to protect a relative or ...
China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...
Coinbase Global (COIN) will begin trading on the S&P 500 (^GSPC) effective today, replacing Discover Financial Services (DFS) ...
At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results